You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bupropion

Showing 1 - 25 of 567
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

Not yet recruiting
  • Obesity
  • Naltrexone-Bupropion (NB) Combination
  • Placebo
  • (no location specified)
Oct 18, 2023

Obesity Trial in New York (Naltrexone-Bupropion Combination)

Recruiting
  • Obesity
  • Naltrexone-Bupropion Combination
  • New York, New York
    Columbia University Medical Center
Jun 16, 2023

Major Depression Trial in Atlanta (Bupropion XL, Escitalopram)

Recruiting
  • Major Depression
  • Atlanta, Georgia
    Emory Clinic
Jan 23, 2023

Healthy Volunteers Trial in Lenexa (BMS-986419, Caffeine, Bupropion)

Not yet recruiting
  • Healthy Volunteers
  • Lenexa, Kansas
    Local Institution - 0001
Jun 27, 2023

Addiction, Opioid Use, Substance Use Disorders Trial (Placebo, Auvelity)

Not yet recruiting
  • Addiction
  • +3 more
  • (no location specified)
Aug 3, 2023

Smoking Cessation, Genetic Predisposition Trial in São Paulo (Varenicline Tartrate or bupropion)

Completed
  • Smoking Cessation
  • Genetic Predisposition
  • Varenicline Tartrate or bupropion
  • São Paulo, Brazil
    Ambulatório de Tratamento Tabagismo - Incor HCFMUSP
Dec 16, 2022

Postpartum Smoking Relapse Trial in Minneapolis (Bupropion Extended Release Oral Tablet, Placebo oral tablet)

Recruiting
  • Postpartum Smoking Relapse
  • Bupropion Extended Release Oral Tablet
  • Placebo oral tablet
  • Minneapolis, Minnesota
    University of Minnesota
Jul 12, 2022

Smoking Cessation Trial in Kansas City (Bupropion)

Not yet recruiting
  • Smoking Cessation
  • Bupropion
  • Kansas City, Missouri
    University of Kansas Medical Center
Feb 7, 2023

Stimulant Use, Relapse, Cognitive Function Trial in Los Angeles (Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion)

Not yet recruiting
  • Stimulant Use
  • +3 more
  • Contrave 8Mg-90Mg Extended-Release Tablet
  • Bupropion
  • Los Angeles, California
    University of California Los Angeles
Aug 31, 2022

Meniere Disease, Ménière's Vertigo, Vertigo, Intermittent Trial in Amherst (Lamotrigine and Bupropion, Placebo)

Recruiting
  • Meniere Disease
  • +3 more
  • Lamotrigine and Bupropion
  • Placebo
  • Amherst, New York
    Dent Neurologic Institute
Jun 17, 2022

Healthy Participants Trial in Lenexa, Salt Lake City (Fluconazole, Bupropion, Itraconazole)

Withdrawn
  • Healthy Participants
  • Lenexa, Kansas
  • +1 more
Mar 10, 2022

Binge-Eating Disorder Trial in New Haven (Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination, Placebo)

Active, not recruiting
  • Binge-Eating Disorder
  • Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination
  • Placebo
  • New Haven, Connecticut
    Yale School of Medicine
Feb 18, 2022

Binge-Eating Disorder, Obesity Trial in New Haven (Naltrexone and Bupropion, Placebo)

Recruiting
  • Binge-Eating Disorder
  • Obesity
  • Naltrexone and Bupropion
  • Placebo
  • New Haven, Connecticut
    Yale Department of Psychiatry
Dec 21, 2022

Smoking Cessation Trial in Charlotte, Raleigh (Bupropion, Zonisamide, Placebo bupropion)

Recruiting
  • Smoking Cessation
  • Bupropion
  • +4 more
  • Charlotte, North Carolina
  • +1 more
Jan 12, 2022

MDD Trial in Bridgewater (bupropion hydrobromide, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • bupropion hydrobromide
  • Placebo
  • Bridgewater, New Jersey
    Valeant
Feb 23, 2022

Obesity, Morbid, Bariatric Surgery Candidate, Medication Persistence Trial (Naltrexone-Bupropion Combination)

Not yet recruiting
  • Obesity, Morbid
  • +2 more
  • Naltrexone-Bupropion Combination
  • (no location specified)
Jul 26, 2022

Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)

Recruiting
  • Sickle Cell Disease
  • San Antonio, Texas
    ICON Early Phase Services, LLC
Jul 31, 2023

Obese, Cigarette-smoking, Schizophrenia Trial (Naltrexone, Placebo Naltrexone, Bupropion)

Completed
Has Results
  • Obese
  • +2 more
  • (no location specified)
Sep 25, 2021

Loss-of-Control Eating, Obesity/Overweight Trial in New Haven (Naltrexone and Bupropion (NB) medication, Placebo)

Enrolling by invitation
  • Loss-of-Control Eating
  • Obesity/Overweight
  • Naltrexone and Bupropion (NB) medication
  • Placebo
  • New Haven, Connecticut
    Yale School of Medicine
Oct 4, 2022

Smoking Cessation Trial in Houston (drug, other, behavioral)

Completed
Has Results
  • Smoking Cessation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 3, 2021

Loss-of-control Eating, Obesity/Overweight Trial in New Haven (drug, behavioral, other)

Recruiting
  • Loss-of-control Eating
  • Obesity/Overweight
  • Naltrexone and Bupropion medication
  • +2 more
  • New Haven, Connecticut
    Yale Department of Psychiatry
Oct 4, 2022

Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

Not yet recruiting
  • Panic Disorder
  • (no location specified)
Feb 20, 2023

Study to Explore Antidepressant Treatment in Korea

Completed
  • Major Depression
  • Seoul, Korea, Republic of
    Pfizer
Nov 14, 2022

Smoking Cessation, Smoking, Tobacco, Mental Illness Trial in San Francisco (Videogame-based physical activity, sedentary

Recruiting
  • Smoking Cessation
  • +3 more
  • Videogame-based physical activity
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Aug 9, 2022

MDD Trial in Belmont (Sertraline, Bupropion)

Not yet recruiting
  • Major Depressive Disorder
  • Belmont, Massachusetts
    McLean Hospital
Sep 8, 2022